In the BioHarmony Drug Report Database

"Preview" Icon

Erlotinib

Tarceva (erlotinib) is a small molecule pharmaceutical. Erlotinib was first approved as Tarceva on 2004-11-18. It is used to treat non-small-cell lung carcinoma in the USA. It has been approved in Europe to treat non-small-cell lung carcinoma and pancreatic neoplasms. The pharmaceutical is active against epidermal growth factor receptor. In addition, it is known to target solute carrier organic anion transporter family member 2B1.

 

Trade Name

 

Tarceva
 

Common Name

 

erlotinib
 

ChEMBL ID

 

CHEMBL553
 

Indication

 

non-small-cell lung carcinoma, pancreatic neoplasms
 

Drug Class

 

Tyrosine kinase inhibitors

Image (chem structure or protein)

Erlotinib structure rendering